# Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects

> **NCT02689661** · — · COMPLETED · sponsor: **Brian Callaghan** · enrollment: 177 (actual)

## Conditions studied

- Metabolic Syndrome
- Obesity
- Neuropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02689661
- **Lead sponsor:** Brian Callaghan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2019-07
- **Final completion:** 2019-12-31
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689661, "Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02689661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*